LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 71

Search options

  1. Article: A 2023 update of choosing wisely "Chemical or thermal occlusion treatments in saphenous vein insufficiency and recurrence": What objectives for what impact?

    Blaise, Sophie

    Journal de medecine vasculaire

    2023  Volume 48, Issue 2, Page(s) 53–54

    MeSH term(s) Humans ; Saphenous Vein/diagnostic imaging ; Saphenous Vein/surgery ; Varicose Veins/therapy
    Language English
    Publishing date 2023-06-28
    Publishing country France
    Document type Editorial
    ISSN 2542-4513
    ISSN 2542-4513
    DOI 10.1016/j.jdmv.2023.06.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Diagnosis of a chronic wound in the special case of a vascular malformation: A proposal of the Wound and Healing Group of the French Society of Vascular Medicine.

    Blaise, Sophie / Malloizel-Delaunay, Julie / Nou, Monira

    Journal de medecine vasculaire

    2024  Volume 49, Issue 2, Page(s) 103–111

    Abstract: Vascular malformations can present with a variety of symptoms and an unpredictable course with the occurrence of wounds. Ulcerations in patients with vascular malformations are fortunately rare. Although few data exist, complications may involve a ... ...

    Abstract Vascular malformations can present with a variety of symptoms and an unpredictable course with the occurrence of wounds. Ulcerations in patients with vascular malformations are fortunately rare. Although few data exist, complications may involve a variety of mechanistic or hemodynamic factors. A rigorous etiological and vascular assessment is therefore essential. In view of the paucity of recommendations, the Wound and Healing Group of the French Society of Vascular Medicine, based on the literature on the subject, presents a number of suggestions for the diagnosis and management of wounds associated with vascular malformations.
    MeSH term(s) Humans ; Vascular Malformations/complications ; Vascular Malformations/diagnostic imaging ; Vascular Malformations/therapy ; Wound Healing ; Chronic Disease
    Language English
    Publishing date 2024-04-17
    Publishing country France
    Document type Journal Article ; Practice Guideline ; Review
    ISSN 2542-4513
    ISSN 2542-4513
    DOI 10.1016/j.jdmv.2024.03.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: La rétention trophoblastique hypervascularisée peut-elle être considérée comme une malformation vasculaire acquise ?

    Zenati, Nora / Seinturier, Christophe / Blaise, Sophie

    Gynecologie, obstetrique, fertilite & senologie

    2023  Volume 51, Issue 7-8, Page(s) 387–389

    Title translation Can retained products of conception be considered as an unclassified acquired vascular malformation?
    MeSH term(s) Humans ; Female ; Uterus ; Fertilization ; Vascular Diseases ; Vascular Malformations ; Retrospective Studies
    Language French
    Publishing date 2023-03-15
    Publishing country France
    Document type Letter
    ZDB-ID 2887456-0
    ISSN 2468-7189
    ISSN (online) 2468-7189
    DOI 10.1016/j.gofs.2023.03.006
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Negative pressure wound therapy with instillation and dwell time in debridement of fibrinous leg ulcers.

    Achiti, Alexandru / Zenati, Nora / Seinturier, Christophe / Cracowski, Jean-Luc / Blaise, Sophie

    Journal of wound care

    2024  Volume 33, Issue 3, Page(s) 166–170

    Abstract: Objective: In conjunction with appropriate wound care, negative pressure wound therapy with instillation and dwell time (NPWTi-d) may be used as an adjunct therapy for acute or hard-to-heal (chronic) wounds, especially when infected. However, there are ... ...

    Abstract Objective: In conjunction with appropriate wound care, negative pressure wound therapy with instillation and dwell time (NPWTi-d) may be used as an adjunct therapy for acute or hard-to-heal (chronic) wounds, especially when infected. However, there are very few data on the use of NPWTi-d in the treatment of fibrinous wounds that are difficult to debride mechanically. The main objective of this study was to describe changes in the fibrin area of such wounds, before and after treatment with NPWTi-d.
    Method: This was a monocentric, observational, prospective pilot study evaluating the NPWTi-d medical device. Eligible patients included in the study were those with hard-to-heal lower limb ulcers who had previously undergone unsuccessful specific debridement treatment for their wound, with failure of manual mechanic debridement for at least six weeks' duration, and whose wounds had a fibrinous surface area of >70% of the total wound surface area. The primary endpoint was the difference in the percentage of fibrinous surface area before and after treatment.
    Results: A total of 14 patients who received treatment for lower limb ulcers between October 2017 and August 2019 were included in the study. There was a significant shrinkage rate of the fibrinous wound surface between the start and end of treatment (83.6±14.5% and 32.2±19.7%, respectively; p<0.001).
    Conclusion: This study showed a significant decrease in fibrin area in wounds treated with NPWTi-d, with good tolerance. We believe that NPWTi-d has its place in the multidisciplinary management of patients with hard-to-heal ulcers. Additional randomised studies are required to confirm these findings.
    Declaration of interest: The authors have no conflicts of interest.
    MeSH term(s) Humans ; Debridement ; Wound Infection/therapy ; Negative-Pressure Wound Therapy ; Ulcer ; Pilot Projects ; Prospective Studies ; Leg Ulcer/therapy ; Fibrin ; Therapeutic Irrigation
    Chemical Substances Fibrin (9001-31-4)
    Language English
    Publishing date 2024-03-11
    Publishing country England
    Document type Observational Study ; Journal Article
    ZDB-ID 1353951-6
    ISSN 0969-0700
    ISSN 0969-0700
    DOI 10.12968/jowc.2024.33.3.166
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: A randomised, open-label, parallel-group, multicentre, comparative study to compare the efficacy and safety of Exufiber® with Aquacel® Extra™ dressings in exuding venous and mixed aetiology leg ulcers.

    Joergensen, Bo / Blaise, Sophie / Svensson, Ann-Sofie

    International wound journal

    2022  Volume 19 Suppl 1, Page(s) 22–38

    Abstract: The performance and safety of Exufiber® gelling fibre and Aquacel® Extra™ Hydrofiber® wound dressings were compared for the management of chronic, exuding leg ulcers. The 6-week study (≤ 24 weeks in a subgroup of subjects) was a randomised, open-label, ... ...

    Abstract The performance and safety of Exufiber® gelling fibre and Aquacel® Extra™ Hydrofiber® wound dressings were compared for the management of chronic, exuding leg ulcers. The 6-week study (≤ 24 weeks in a subgroup of subjects) was a randomised, open-label, parallel-group, multicentre, non-inferiority design. Adults (n = 248, 30-97 years of age) were randomised to either Exufiber® or Aquacel® Extra™ dressing. The dressings were applied at baseline and evaluations of wound condition and performance of the dressing were recorded at 1, 2, 3, 4, and 6 weeks. The primary efficacy endpoint was the percentage reduction in wound area at 6 weeks relative to baseline, in the per protocol (PP) population. A median relative reduction of 50% for Exufiber® (n = 100) vs 42% for Aquacel® Extra™ (n = 107) was demonstrated in the PP population (P = 0.093) and confirmed in the intention-to-treat population. As the mean and 95% confidence interval for the difference in relative wound area reduction between groups at 6 weeks was -29.4% (-63.5; 3.2), and the lower limit did not exceed 12%, non-inferiority of Exufiber® was concluded. Both dressings were well tolerated and no safety concerns were identified in both groups. Clinicians' satisfaction with the dressings was higher for Exufiber® than for Aquacel® Extra™ in terms of ease of use and management of exudate, slough, and blood.
    MeSH term(s) Adult ; Bandages ; Carboxymethylcellulose Sodium ; Humans ; Leg Ulcer/therapy ; Prospective Studies ; Treatment Outcome ; Wound Healing
    Chemical Substances Carboxymethylcellulose Sodium (K679OBS311)
    Language English
    Publishing date 2022-09-16
    Publishing country England
    Document type Journal Article ; Multicenter Study ; Randomized Controlled Trial
    ZDB-ID 2170920-8
    ISSN 1742-481X ; 1742-4801
    ISSN (online) 1742-481X
    ISSN 1742-4801
    DOI 10.1111/iwj.13913
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Skin necrosis and calcifications after extravasation of vancomycin: a localised form of calciphylaxis?

    Zenati, Nora / Khouri, Charles / Schwebel, Carole / Blaise, Sophie

    Journal of wound care

    2021  Volume 30, Issue 5, Page(s) 390–393

    Abstract: Vancomycin is a tricyclic glycopeptide antibiotic produced ... ...

    Abstract Vancomycin is a tricyclic glycopeptide antibiotic produced from
    MeSH term(s) Anti-Bacterial Agents/adverse effects ; Calcinosis/chemically induced ; Calciphylaxis/chemically induced ; Humans ; Male ; Methicillin-Resistant Staphylococcus aureus ; Middle Aged ; Necrosis/chemically induced ; Vancomycin/adverse effects
    Chemical Substances Anti-Bacterial Agents ; Vancomycin (6Q205EH1VU)
    Language English
    Publishing date 2021-05-12
    Publishing country England
    Document type Case Reports ; Journal Article
    ZDB-ID 1353951-6
    ISSN 0969-0700
    ISSN 0969-0700
    DOI 10.12968/jowc.2021.30.5.390
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Comparative evaluation of socioeconomic insecurity in peripheral and coronary artery disease patients.

    Joly, Marion / Gillois, Pierre / Satger, Bernadette / Blaise, Sophie / Pernod, Gilles

    Journal de medecine vasculaire

    2022  Volume 47, Issue 5-6, Page(s) 220–227

    Abstract: Background: Cardiovascular disease represents the leading cause of death worldwide. Socioeconomic deprivation is a risk factor for cardiovascular disease. We have previously shown that precariousness was more frequent in symptomatic peripheral artery ... ...

    Abstract Background: Cardiovascular disease represents the leading cause of death worldwide. Socioeconomic deprivation is a risk factor for cardiovascular disease. We have previously shown that precariousness was more frequent in symptomatic peripheral artery disease (PAD) patients than in the general population. According to a previous study, coronary artery disease (CAD) patients have a higher level of education than CAD with PAD, but no study directly compared the level of precariousness in PAD and CAD patients.
    Aim: To measure and compare the level of socioeconomic insecurity in patients suffering from symptomatic PAD with those suffering from isolated CAD, i.e without symptomatic PAD.
    Methods: We conducted an observational, cohort, prospective, multicenter study. Patients suffering from symptomatic PAD or CAD were recruited through the medical or surgical vascular or cardiology departments, or the vascular rehabilitation center. The EPICES score and the INSEE parameters were used for analysis. The individual is considered precarious when his or her score is greater than or equal to 30. Cardiovascular risk factors and peripheral arterial disease stages were also collected.
    Results: In total, 230 patients were included. According to the EPICES score, 47.8% [95%CI, 38.7-56.7] of patients with symptomatic PAD were in a precarious situation compared to 17.4% [95%CI, 10.5-24.3] of patients suffering from isolated CAD (P<0.001). The mean EPICES score was 33.3 (SD 22.5) in the PAD and 16.9 (SD 17.02) in the CAD population, respectively (P<0.001). In the PAD population, the level of education was low, with an under-representation of patients with a baccalaureate or higher education degree: 21.7% [95%CI, 14.2-29.3] vs. 41.7% [95%CI, 32.7-50.7] in the PAD and CAD populations, respectively. There was also an under-representation of executives and intellectual and intermediate professions in the PAD population, 18.3% [95%CI, 11.2-25.3], compared to the CAD population, 31.3% [95%CI, 22.8-39.8].
    Conclusion: PAD patients are more precarious than patients suffering from CAD. A better detection of socioeconomic deprivation in patients suffering from peripheral arterial disease could allow comprehensive care and thus hope for an improvement in terms of morbidity and mortality.
    MeSH term(s) Female ; Male ; Humans ; Coronary Artery Disease/epidemiology ; Prospective Studies ; Peripheral Arterial Disease/diagnosis ; Peripheral Arterial Disease/epidemiology ; Risk Factors ; Educational Status
    Language English
    Publishing date 2022-10-19
    Publishing country France
    Document type Observational Study ; Multicenter Study ; Journal Article
    ISSN 2542-4513
    ISSN 2542-4513
    DOI 10.1016/j.jdmv.2022.10.001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Localised intravascular coagulation complicating venous malformations: Clinical characterisation.

    Blaise, Sophie / Soya, Esaie / Nou, Monira / Malloizel-Delaunay, Julie / Thiel, Hélène / Bisdorff-Bresson, Annouk / Seinturier, Christophe

    Phlebology

    2023  Volume 39, Issue 3, Page(s) 169–173

    Abstract: Objective: The International Union of Phlebology recommends measuring at least D-dimer and fibrinogen levels in the diagnosis of extensive extra-truncular venous malformations, with a surface area of 10 cm: Method: This study was an observational and ...

    Abstract Objective: The International Union of Phlebology recommends measuring at least D-dimer and fibrinogen levels in the diagnosis of extensive extra-truncular venous malformations, with a surface area of 10 cm
    Method: This study was an observational and multicentre study. The objective was to explore the presence of a possible coagulation disorder among patients with venous malformation. The primary endpoint was to characterise venous malformations with increased D-dimer levels.
    Results: The majority of the 72 venous malformations were located in the trunk region, mostly in intramuscular or subcutaneous locations. There were 72 venous malformations with increased D-dimer levels including 3 with biological disseminated intravascular coagulation (elevated D-dimer and fibrinogen <1 g/L). The anticoagulant treatments administered were very heterogeneous in class and dosage, and at the end of the treatment, 17 elevated D-dimers were persistent, 9 venous malformations remained painful and 27 showed thrombotic regression.
    Conclusion: Venous vascular malformations are probably underestimated and should probably be explored more systematically in terms of coagulation disorder regardless of size or symptomatology. The therapeutic recommendations to treat localised intravascular coagulation with low-molecular weight are not widely applied. Studies are needed, in particular to assess the role of oral anticoagulants in the management of coagulation disorder among patients with venous malformation.
    MeSH term(s) Humans ; Anticoagulants/therapeutic use ; Vascular Malformations/diagnosis ; Blood Coagulation Disorders ; Veins/abnormalities ; Fibrinogen/therapeutic use ; Fibrin Fibrinogen Degradation Products
    Chemical Substances Anticoagulants ; Fibrinogen (9001-32-5) ; Fibrin Fibrinogen Degradation Products
    Language English
    Publishing date 2023-11-18
    Publishing country England
    Document type Observational Study ; Multicenter Study ; Journal Article
    ZDB-ID 645172-x
    ISSN 1758-1125 ; 0268-3555
    ISSN (online) 1758-1125
    ISSN 0268-3555
    DOI 10.1177/02683555231216349
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Assessment of digital perfusion as a surrogate outcome in Raynaud's phenomenon clinical trials.

    Guigui, Alicia / Liaigre, Léa / Manceau, Marc / Gaget, Olivier / Cracowski, Jean-Luc / Blaise, Sophie / Khouri, Charles / Roustit, Matthieu

    Rheumatology (Oxford, England)

    2023  

    Abstract: Objectives: Measurement of digital perfusion, sometimes coupled with a cold challenge, has been widely used as an objective outcome in trials evaluating drug therapies in Raynaud's Phenomenon (RP), in addition to patient-reported outcomes or to ... ...

    Abstract Objectives: Measurement of digital perfusion, sometimes coupled with a cold challenge, has been widely used as an objective outcome in trials evaluating drug therapies in Raynaud's Phenomenon (RP), in addition to patient-reported outcomes or to establish the proof-of-concept in preliminary studies. However, whether digital perfusion is a valid surrogate for clinical outcomes in RP trials has never been explored. The principal aim of this study was to evaluate the potential surrogacy of digital perfusion, by combining individual-level and trial-level data.
    Methods: We used individual data from a series of n-of-1 trials, and trial data from a network meta-analysis. We estimated individual-level surrogacy through coefficients of determination between digital perfusion and clinical outcomes (R2ind). We further calculated the coefficients of determination between treatment effect on the clinical outcomes and on digital perfusion, at the individual level (R2TEInd) and at the trial level (R2trial), using non-weighted linear regression, with their 95% CI calculated through bootstrapping.
    Results: Results from 33 patients and 24 trials were included in the final analysis. At the individual level, there was no correlation between digital perfusion and clinical outcomes at rest and in response to various cooling tests (the highest R2ind was 0.03 [-0.07; 0.09]), and R2TEinf was also very low 0.07 [0; 0.29]. At the trial level, the highest value of R2trial was 0.1 [0; 0.477].
    Conclusions: Digital perfusion, at rest or in response to a cold challenge, and whatever the method used, does not fulfill the criteria of a valid surrogate for existing patient-reported outcomes in RP trials.
    Language English
    Publishing date 2023-07-08
    Publishing country England
    Document type Journal Article
    ZDB-ID 1464822-2
    ISSN 1462-0332 ; 1462-0324
    ISSN (online) 1462-0332
    ISSN 1462-0324
    DOI 10.1093/rheumatology/kead337
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Use of Bisphosphonates and the Risk of Skin Ulcer: A National Cohort Study Using Data from the French Health Care Claims Database.

    Jambon-Barbara, Clément / Bernardeau, Claire / Bezin, Julien / Roustit, Matthieu / Blaise, Sophie / Cracowski, Jean-Luc / Khouri, Charles

    Drug safety

    2023  Volume 46, Issue 9, Page(s) 905–916

    Abstract: Introduction: Previous pre-clinical and pharmacovigilance disproportionality analyses highlighted a safety signal of cutaneous ulcer with bisphosphonate use. Therefore, our objective is to evaluate this risk and assess whether unmeasured confounding ... ...

    Abstract Introduction: Previous pre-clinical and pharmacovigilance disproportionality analyses highlighted a safety signal of cutaneous ulcer with bisphosphonate use. Therefore, our objective is to evaluate this risk and assess whether unmeasured confounding factors could explain this association.
    Methods: This study is a population-based cohort study from a representative sample (1/97th) of the French health insurance claims database: Echantillon Généraliste des Bénéficiaires (EGB) from 2006 to 2019. To limit the impact of our study design and methodological choices on any association between skin ulceration and exposure to bisphosphonates, we used several methods: a Cox proportional hazards analysis and a prior event rate ratio (PERR) analysis, using two propensity matched control groups, and either the first episode of incident ulceration or multiple event-time outcomes.
    Results: There were 7402 individuals newly exposed to bisphosphonates matched to 29,605 unexposed individuals on propensity score. The primary outcome was skin ulcer occurrence assessed by at least 2 deliveries of wound dressing during the period of one month. Among 6911 individuals newly exposed to bisphosphonates and 28,072 unexposed individuals with no previous skin ulcer, the Cox regression yielded a hazard ratio (HR) of 1.40 (95% CI 1.26-1.56) for newly exposed individuals. Among 7402 exposed and 29,605 unexposed individuals, the PERR analysis found a non-significant HR of 1.03 (95% CI 0.87-1.24). Results were similar on the different sensitivity analyses.
    Conclusion: No association between bisphosphonate and skin ulcers was found in the French population. The association observed in previous pharmacovigilance studies and in the Cox regression analysis is likely due to unmeasured confounding factors.
    MeSH term(s) Humans ; Cohort Studies ; Diphosphonates/adverse effects ; Delivery of Health Care ; Proportional Hazards Models ; Skin Ulcer
    Chemical Substances Diphosphonates
    Language English
    Publishing date 2023-08-02
    Publishing country New Zealand
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1018059-x
    ISSN 1179-1942 ; 0114-5916
    ISSN (online) 1179-1942
    ISSN 0114-5916
    DOI 10.1007/s40264-023-01336-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top